On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus. On November 5th, 2021, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. iHealth has since been a major supplier of at-home tests to the federal government, state governments, nonprofit organizations, and individuals in the U.S. market. In January 2022, iHealth was awarded a contract from the U.S. Department of Defense to deliver 354 million tests to American families. iHealth now brings at-home COVID tests to the Hong Kong market to further fulfill the company’s responsibilities in fighting against the virus.

Shipping and Returns

—The Impact of the Covid-19 Pandemic on Shipping—
Delivery times vary according to your selected delivery address, the availability of your items, and the time of day you place your order. Shipping rates are based on weight, the number of iHealth products ordered, and your selected delivery address. Shipping rates are displayed during the checkout process. We do not offer the ability to select a shipping option for your order. We also do not currently offer any expedited shipping options.

Orders generally ship the next business day ( Saturday and Sunday are not the business day), if the items are in stock and the order is placed prior to 3:00 pm PST. However, we cannot guarantee your order will ship the next business day, regardless of the shipping method you select. We make every effort to send out your order as quickly as possible.

Shipping rates are based on weight, the number of iHealth products ordered, and your selected delivery address. Shipping rates are displayed during the checkout process.

Incorrect Address

Please verify your address when ordering, we are unable to fix an incorrect shipping address on an order once it is in transit. If your order is in transit with an incorrect address, please reach out to your carrier to reroute the package. iHealth is not able to have packages rerouted or contact the carrier on your behalf.

Refunds will not be issued for packages that were shipped to an incorrect address but it may be possible for a replacement package to be sent, please contact the customer service team to see if you are eligible.

Return Policy

The iHealth COVID-19 Antigen Rapid Test and all face masks are Non-returnable & Non-refundable as they are considered personal-use items. Replacement may be shipped if the item is defective.

365 Day Limited Warranty

Spin to win Spinner icon